| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |